Age, median (range)
|
60 (18–95)
|
61 (28–83)
|
57 (30–80)
|
58 (28–83)
|
61 (30–76)
|
Female sex, N (%)
|
458 (66.2)
|
33 (82.5)
|
28 (82.4)
|
61 (82.4)
|
8 (66.7)
|
Self-reported race/ethnicity, N (%)
|
African American/African
|
156 (22.5)
|
6 (15.0)
|
18 (52.9)
|
24 (32.4)
|
3 (25.0)
|
East/Southeast Asian
|
26 (3.8)
|
2 (5.0)
|
0
|
2 (2.7)
|
3 (25.0)
|
European
|
186 (26.9)
|
20 (50.0)
|
1 (2.9)
|
21 (28.4)
|
5 (41.7)
|
Hispanic/Latinx
|
249 (36.0)
|
8 (20.0)
|
15 (44.1)
|
23 (31.1)
|
0
|
Native American
|
1 (0.1)
|
0
|
0
|
0
|
0
|
Other
|
41 (5.9)
|
3 (7.5)
|
0
|
3 (4.1)
|
1 (8.3)
|
South Asian
|
9 (1.3)
|
0
|
0
|
0
|
0
|
Multiple selected
|
22 (3.2)
|
1 (2.5)
|
0
|
1 (1.4)
|
0
|
Not available
|
2 (0.3)
|
0
|
0
|
0
|
0
|
Spanish as preferred language, N (%)
|
–
|
0
|
3 (8.8)
|
3 (4.1)
|
–
|
Prior knowledge of genomic risk, N (%)
|
–
|
14 (35.0)
|
1 (2.9)
|
15 (20.3)
|
–
|
Mode of result disclosure, N (%)
|
–
| | | |
–
|
In-person
| |
24 (60.0)
|
26 (76.5)
|
50 (67.6)
| |
Telemedicine
| |
16 (40.0)
|
8 (23.5)
|
24 (32.4)
| |